Clinical Trials Directory

Trials / Terminated

TerminatedNCT04586270

A Study of TAS0612 in Participants With Advanced or Metastatic Solid Tumor Cancer

A Phase 1 Study of TAS0612 in Patients With Locally Advanced or Metastatic Solid Tumors

Status
Terminated
Phase
Phase 1
Study type
Interventional
Enrollment
47 (actual)
Sponsor
Taiho Oncology, Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to see if TAS0612 is safe in participants with advanced or metastatic solid tumor cancer.

Conditions

Interventions

TypeNameDescription
DRUGTAS0612oral tablets

Timeline

Start date
2020-10-15
Primary completion
2024-11-14
Completion
2024-11-14
First posted
2020-10-14
Last updated
2025-03-13

Locations

4 sites across 2 countries: United States, France

Regulatory

Source: ClinicalTrials.gov record NCT04586270. Inclusion in this directory is not an endorsement.

A Study of TAS0612 in Participants With Advanced or Metastatic Solid Tumor Cancer (NCT04586270) · Clinical Trials Directory